KPIs & Operating Metrics(New)
Growth Metrics

Charles River Laboratories International (CRL) Cash from Operations (2016 - 2025)

Historic Cash from Operations for Charles River Laboratories International (CRL) over the last 17 years, with Q3 2025 value amounting to $213.8 million.

  • Charles River Laboratories International's Cash from Operations fell 1507.83% to $213.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $749.5 million, marking a year-over-year decrease of 586.19%. This contributed to the annual value of $734.6 million for FY2024, which is 741.03% up from last year.
  • As of Q3 2025, Charles River Laboratories International's Cash from Operations stood at $213.8 million, which was down 1507.83% from $204.6 million recorded in Q2 2025.
  • In the past 5 years, Charles River Laboratories International's Cash from Operations ranged from a high of $251.8 million in Q3 2024 and a low of $102.6 million during Q1 2022
  • Its 5-year average for Cash from Operations is $178.4 million, with a median of $174.7 million in 2021.
  • As far as peak fluctuations go, Charles River Laboratories International's Cash from Operations skyrocketed by 14818.34% in 2021, and later tumbled by 3971.06% in 2022.
  • Quarter analysis of 5 years shows Charles River Laboratories International's Cash from Operations stood at $229.3 million in 2021, then grew by 2.4% to $234.8 million in 2022, then dropped by 5.88% to $220.9 million in 2023, then dropped by 27.87% to $159.4 million in 2024, then skyrocketed by 34.18% to $213.8 million in 2025.
  • Its Cash from Operations was $213.8 million in Q3 2025, compared to $204.6 million in Q2 2025 and $171.7 million in Q1 2025.